Fulminant Myocarditis After mRNA COVID-19 Vaccine Evolving to Giant Cell Myocarditis
Erika Ouimet-Grennan(Montreal Heart Institute), Jacinthe Boulet(Montreal Heart Institute), Maxime Tremblay‐Gravel(Montreal Heart Institute), Matthieu Pelletier‐Galarneau(Montreal Heart Institute), Marie-Claude Parent(Montreal Heart Institute)
Cited by 1
Related Papers
Inflammation in heart failure: pathophysiology and therapeutic strategies
|Inflammation Research|2024|129
Respiratory infections and the autumn increase in asthma morbidity
|European Respiratory Journal|1996|114
Statin Use and Risk of Vascular Events Among Cancer Patients After Radiotherapy to the Thorax, Head, and Neck
|Journal of the American Heart Association|2019|87
Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease
|Metabolism|2021|80
Left Ventricular Reverse Remodeling in Heart Failure: Remission to Recovery
|Structural Heart|2021|68